We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Sayana-Uniject Volumetric Delivery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01298479
Recruitment Status : Completed
First Posted : February 17, 2011
Last Update Posted : February 17, 2011
Information provided by:

December 16, 2010
February 17, 2011
February 17, 2011
May 2010
June 2010   (Final data collection date for primary outcome measure)
Weight of drug suspension delivered (estimated by change in mass of the Uniject(TM) delivery system). [ Time Frame: Visit 1 ]
Same as current
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
Sayana-Uniject Volumetric Delivery
Quantitative Determination of the Volume of Suspension Delivered Via the Uniject Delivery System Following Simulated Subcutaneous Injection by Healthcare Professionals Into a Synthetic Subcutaneous Injection Training Device
The purpose of this study is to determine the volumetric delivery of the Uniject.
Observe subjects deliver the drug None used
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Volume Delivery.
Other: Uniject
single use container
Group 1
All subjects
Intervention: Other: Uniject
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
June 2010
June 2010   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Nurses

Exclusion Criteria:

  • Non-nurses
Sexes Eligible for Study: All
18 Years to 65 Years   (Adult)
Contact information is only displayed when the study is recruiting subjects
Not Provided
Not Provided
Director, Clinical Trial Disclosure Group, Pfizer, Inc.
Not Provided
Study Director: Pfizer CT.gov Call Center Pfizer
February 2011